Related Experiment Video
Updated: May 9, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
Complexity and diversity of hepatitis B virus quasispecies: correlation with long-term entecavir antiviral efficacy
Jin Tong1, Qing-Ling Li, Ai-Long Huang
1Department of Gastroenterology and Hepatology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Abstract:
This study was undertaken to determine the complexity and diversity of hepatitis B virus (HBV) quasispecies during long-term antiviral therapy and examine their impacts on therapeutic outcome. Six chronic hepatitis B patients receiving entecavir monotherapy (0.5mg/day) for 3 years were enrolled. The reverse transcriptase region of the HBV polymerase gene was sequenced and HBV quasispecies complexity and diversity were calculated. Sustained virological response (SVR) was defined as serum HBV DNA <57 IU/ml from 48 weeks after treatment to the end of follow up. Four patients achieved a SVR and the other two had a virological breakthrough at week 24. Despite comparable baseline levels, the complexity and diversity of HBV quasispecies were significantly (p<0.05) reduced in sustained responders versus the patients with a virological breakthrough 48 weeks after treatment. Thus, reduction in HBV quasispecies complexity and diversity may predict an SVR to long-term entecavir monotherapy.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Retrovirus Life Cycles
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Viruses with RNA Genomes

